1. AstraZeneca's Dr. Niko Andre Discusses Leukemia & Lymphoma Drug CALQUENCE | Interview

    AstraZeneca's Dr. Niko Andre Discusses Leukemia & Lymphoma Drug CALQUENCE | Interview

    4
    0
    170
  2. AstraZeneca's Dr. Niko Andre Discusses Leukemia & Lymphoma Drug CALQUENCE | Interview

    AstraZeneca's Dr. Niko Andre Discusses Leukemia & Lymphoma Drug CALQUENCE | Interview

    30
  3. AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager

    AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager

    6
    0
    103